AAAAAA
Results:
1-16
|
Results: 16
Authors:
Preston, SL
Drusano, GL
Citation: Sl. Preston et Gl. Drusano, Telithromycin - A once-daily, broad-spectrum ketolide for treatment of various respiratory infections, FORMULARY, 36(2), 2001, pp. 101
Authors:
Behrman, HR
Kodaman, PH
Preston, SL
Gao, SP
Citation: Hr. Behrman et al., Oxidative stress and the ovary, J SOC GYN I, 8(1), 2001, pp. S40-S42
Authors:
Drusano, GL
Preston, SL
Owens, RC
Ambrose, PG
Citation: Gl. Drusano et al., Fluoroquinolone pharmacodynamics, CLIN INF D, 33(12), 2001, pp. 2091-2092
Authors:
Sadler, BM
Piliero, PJ
Preston, SL
Lloyd, PP
Lou, Y
Stein, DS
Citation: Bm. Sadler et al., Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers, AIDS, 15(8), 2001, pp. 1009-1018
Authors:
Drusano, GL
Preston, SL
Smee, D
Bush, K
Bailey, K
Sidwell, RW
Citation: Gl. Drusano et al., Pharmacodynamic evaluation of RWJ-270201, a novel neuraminidase inhibitor,in a lethal murine model of influenza predicts efficacy for once-daily dosing, ANTIM AG CH, 45(7), 2001, pp. 2115-2118
Authors:
Drusano, GL
Preston, SL
Hardalo, C
Hare, R
Banfield, C
Andes, D
Vesga, O
Craig, WA
Citation: Gl. Drusano et al., Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint, ANTIM AG CH, 45(1), 2001, pp. 13-22
Authors:
Drusano, GL
Bilello, JA
Preston, SL
O'Mara, E
Kaul, S
Schnittman, S
Echols, R
Citation: Gl. Drusano et al., Hollow-fiber unit evaluation of a new human immunodeficiency virus type 1 protease inhibitor, BMS-232632, for determination of the linked pharmacodynamic variable, J INFEC DIS, 183(7), 2001, pp. 1126-1129
Authors:
Takami, M
Preston, SL
Behrman, HR
Citation: M. Takami et al., Eicosatetraynoic and eicosatriynoic acids, lipoxygenase inhibitors, block meiosis via antioxidant action, AM J P-CELL, 278(4), 2000, pp. C646-C650
Authors:
Drusano, GL
Preston, SL
Van Guilder, M
North, D
Gombert, M
Oefelein, M
Boccumini, L
Weisinger, B
Corrado, M
Kahn, J
Citation: Gl. Drusano et al., A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin, ANTIM AG CH, 44(8), 2000, pp. 2046-2051
Authors:
Drusano, GL
D'Argenio, DZ
Preston, SL
Barone, C
Symonds, W
LaFon, S
Rogers, M
Prince, W
Bye, A
Bilello, JA
Citation: Gl. Drusano et al., Use of drug effect interaction modeling with Monte Carlo simulation to examine the impact of dosing interval on the projected antiviral activity of the combination of abacavir and amprenavir, ANTIM AG CH, 44(6), 2000, pp. 1655-1659
Authors:
Guarnaccia, MM
Takami, M
Jones, EE
Preston, SL
Behrman, HR
Citation: Mm. Guarnaccia et al., Luteinizing hormone depletes ascorbic acid in preovulatory follicles, FERT STERIL, 74(5), 2000, pp. 959-963
Authors:
Preston, SL
Drusano, GL
Citation: Sl. Preston et Gl. Drusano, Gatifloxacin - A new fluoroquinolone for use in community-acquired pneumonia and other infections, FORMULARY, 34(12), 1999, pp. 1002
Authors:
Tam, VH
Preston, SL
Briceland, LL
Citation: Vh. Tam et al., Once-daily aminoglycosides in the treatment of gram-positive endocarditis, ANN PHARMAC, 33(5), 1999, pp. 600-606
Authors:
Takami, M
Preston, SL
Toyloy, VA
Behrman, HR
Citation: M. Takami et al., Antioxidants reversibly inhibit the spontaneous resumption of meiosis, AM J P-ENDO, 39(4), 1999, pp. E684-E688
Authors:
Preston, SL
Drusano, GL
Glue, P
Nash, J
Gupta, SK
McNamara, P
Citation: Sl. Preston et al., Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology, ANTIM AG CH, 43(10), 1999, pp. 2451-2456
Authors:
Preston, SL
Drusano, GL
Citation: Sl. Preston et Gl. Drusano, Pharmacology of antimicrobials, CLINICAL INFECTIOUS DISEASES, 1999, pp. 217-223
Risultati:
1-16
|